These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 6395951

  • 1. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
    Sladek NE, Doeden D, Powers JF, Krivit W.
    Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
    [Abstract] [Full Text] [Related]

  • 2. Half-life of oxazaphosphorines in biological fluids.
    Sladek NE, Powers JF, Grage GM.
    Drug Metab Dispos; 1984 Oct; 12(5):553-9. PubMed ID: 6149904
    [Abstract] [Full Text] [Related]

  • 3. Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
    Chen TL, Kennedy MJ, Anderson LW, Kiraly SB, Black KC, Colvin OM, Grochow LB.
    Drug Metab Dispos; 1997 May; 25(5):544-51. PubMed ID: 9152592
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat.
    Hong PS, Srigritsanapol A, Chan KK.
    Drug Metab Dispos; 1991 May; 19(1):1-7. PubMed ID: 1673381
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats.
    Powers JF, Sladek NE.
    Cancer Res; 1983 Mar; 43(3):1101-6. PubMed ID: 6825082
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients.
    Ren S, Kalhorn TF, McDonald GB, Anasetti C, Appelbaum FR, Slattery JT.
    Clin Pharmacol Ther; 1998 Sep; 64(3):289-301. PubMed ID: 9757153
    [Abstract] [Full Text] [Related]

  • 10. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
    Struck RF, Alberts DS.
    Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
    [Abstract] [Full Text] [Related]

  • 11. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
    Motzer RJ, Gulati SC, Tong WP, Menendez-Botet C, Lyn P, Mazumdar M, Vlamis V, Lin S, Bosl GJ.
    Cancer Res; 1993 Aug 15; 53(16):3730-5. PubMed ID: 8393380
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy.
    Anderson LW, Chen TL, Colvin OM, Grochow LB, Collins JM, Kennedy MJ, Strong JM.
    Clin Cancer Res; 1996 Sep 15; 2(9):1481-7. PubMed ID: 9816324
    [Abstract] [Full Text] [Related]

  • 15. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
    Dirven HA, van Ommen B, van Bladeren PJ.
    Cancer Res; 1994 Dec 01; 54(23):6215-20. PubMed ID: 7954469
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of high-dose cyclophosphamide for bone marrow transplantation.
    Fasola G, Lo Greco P, Calori E, Zilli M, Verlicchi F, Motta MR, Ricci P, Baccarani M, Tura S.
    Haematologica; 1991 Dec 01; 76(2):120-5. PubMed ID: 1937169
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thermodynamic analysis of the reaction of phosphoramide mustard with protector thiols.
    Seitz DE, Katterjohn CJ, Rinzel SM, Pearce HL.
    Cancer Res; 1989 Jul 01; 49(13):3525-8. PubMed ID: 2499418
    [Abstract] [Full Text] [Related]

  • 19. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF.
    Teratology; 1989 Jul 01; 40(1):11-20. PubMed ID: 2763206
    [Abstract] [Full Text] [Related]

  • 20. Vomiting induced by cyclophosphamide and phosphoramide mustard in cats.
    Fetting JH, McCarthy LE, Borison HL, Colvin M.
    Cancer Treat Rep; 1982 Aug 01; 66(8):1625-9. PubMed ID: 7105052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.